首页|丹参注射液辅助治疗对冠心病心绞痛患者心绞痛发作情况及血管内皮功能的影响

丹参注射液辅助治疗对冠心病心绞痛患者心绞痛发作情况及血管内皮功能的影响

扫码查看
目的 探讨丹参注射液辅助治疗对冠心病心绞痛患者心绞痛发作情况及血管内皮功能的影响。方法 择取 2021年 5 月至 2023 年 5 月于上饶市中心医院接受治疗的 93 例冠心病心绞痛患者,用随机数字表法分成对照组(n=46)、试验组(n=47)。对照组予常规西药治疗,在其基础上,试验组予丹参注射液辅助治疗,对比两组临床疗效、心绞痛发作情况、心功能、血管内皮功能、炎症因子水平和不良反应情况。结果 试验组临床有效率较对照组高(P<0。05)。治疗后,两组心绞痛持续时间均缩短,心绞痛发作频次均减少,且试验组较对照组改善更优(P<0。05);两组心输出量(CO)、每博输出量(SV)、左心室射血分数(LVEF)均增加,且试验组较对照组高(P<0。05);两组内皮素-1(ET-1)均降低,一氧化氮(NO)均增加,且试验组较对照组改善更优(P<0。05);两组CRP与IL-6 均降低,且试验组较对照组低(P<0。05)。治疗期间两组均未出现明显不良反应。结论 丹参注射液辅助治疗冠心病心绞痛疗效确切,可改善血管内皮功能,拮抗炎性反应,减少心绞痛发作情况,改善心功能,且安全性较高。
Effect of Salvia Miltiorrhiza Injection Adjuvant Therapy on Angina Pectoris Attack and Vascular Endothelial Function in Patients with Angina Pectoris of Coronary Heart Disease
Objective To investigate the effect of salvia miltiorrhiza injection on angina pectoris and vascular endothelial function in patients with coronary heart disease(CHD).Methods A total of 93 patients with angina pectoris of CHD treated in Shangrao Central Hospital from May 2021 to May 2023 were randomly divided into control group(n=46)and experimental group(n=47).The control group was treated with conventional western medicine,and the experimental group was treated with salvia miltiorrhiza injection.The clinical efficacy,angina pectoris attack,heart function,vascular endothelial function,inflammatory factor levels and adverse reactions of the two groups were compared.Results The clinical effective rate of experimental group was higher than that of control group(P<0.05).After treatment,the duration of angina pectoris in both groups was shortened,and the frequency of angina pectoris attack was reduced,and the duration and frequency of angina pectoris in experimental group was better than that in control group(P<0.05);cardiac output(CO),stroke volume(SV)and left ventricular ejection fraction(LVEF)were increased in both groups,and the experimental group were higher than those in control group(P<0.05);endothelin-1(ET-1)decreased and nitric oxide(NO)increased in both groups,and the improvement in experimental group was better than that in control group(P<0.05);CRP and IL-6 were decreased in both groups,and the experimental group were lower than those in control group(P<0.05).There were no obvious adverse reactions between the two groups.Conclusion Salvia miltiorrhiza injection is effective in the adjuvant treatment of angina pectoris in coronary heart disease.It can improve vascular endothelial function,antagonize inflammatory response,reduce the incidence of angina pectoris,improve cardiac function,and has high safety.

Angina pectoris of coronary heart diseaseSalvia miltiorrhiza injectionAngina pectoris attackVascular endothelial function

陈旭、章玲

展开 >

上饶市中心医院,江西 上饶 334000

冠心病心绞痛 丹参注射液 心绞痛发作 血管内皮功能

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(3)